Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001387131-19-001980
Filing Date
2019-03-18
Accepted
2019-03-18 07:50:32
Documents
8
Period of Report
2018-12-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT tnxp-10k_123118.htm 10-K 2345488
2 SECOND AMENDMENT OF LEASE AND ASSIGNMENT OF LEASE ex10-17.htm EX-10.17 50483
3 LIST OF SUBSIDIARIES ex21-01.htm EX-21.01 7349
4 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM ex23-01.htm EX-23.01 4044
5 CERTIFICATION OF CHIEF EXECUTIVE OFFICER ex31-01.htm EX-31.01 10565
6 CERTIFICATION OF CHIEF FINANCIAL OFFICER ex31-02.htm EX-31.02 9881
7 CERTIFICATIONS OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER ex32-01.htm EX-32.01 6293
8 GRAPHIC ex10-17_img001.jpg GRAPHIC 35780
  Complete submission text file 0001387131-19-001980.txt   2484601
Mailing Address 509 MADISON AVE. - SUITE 306 NEW YORK NY 10022
Business Address 509 MADISON AVE. - SUITE 306 NEW YORK NY 10022 1-800-849-7894
Tonix Pharmaceuticals Holding Corp. (Filer) CIK: 0001430306 (see all company filings)

EIN.: 261434750 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36019 | Film No.: 19686836
SIC: 2834 Pharmaceutical Preparations